申请人:Inthera Bioscience AG
公开号:US20220213057A1
公开(公告)日:2022-07-07
The present invention relates to novel compounds of formula (I) or formula (Ia)
pharmaceutically-acceptable salts, hydrates, solvates, or stereoisomers thereof, and pharmaceutical compositions of these compounds which are useful for preventive and therapeutic use in human and veterinary medicine.